HomeClinical TopicsExperimental drug may stop cancer-induced cachexia

Experimental drug may stop cancer-induced cachexia

Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health, according to a study in the Journal of the National Cancer Institute. Read more and read the study abstract.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content